Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly optimized …

The recursion mindset is the deep belief and commitment to industrializing drug discovery through automation, algorithms, and data to deliver on our mission. This is made manifest through our …

At Recursion, Dr. Khan has combined bold vision with disciplined leadership to advance value and impact.

Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!

Oct 29, 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a wide range of …

Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …

Nov 5, 2025 · Explore Recursion's latest blog posts on AI, automation, and molecular modeling in drug discovery. Stay informed with cutting-edge insights!

Ben Taylor comes to Recursion after over 4 years as the CFO of Exscientia. Ben has more than two decades of experience in healthcare investment banking and executive roles, including 15 years at …

Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects technical …

Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!